NASDAQ: EIKN
Eikon Therapeutics Inc Stock Ownership - Who owns Eikon Therapeutics?

Insider buying vs selling

Have Eikon Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Column Group IV GP LP10% Owner2026-09-0389,200$11.56
$1.03MBuy
Column Group IV GP LP10% Owner2026-02-0649,556$18.00
$892.01kBuy
Column Group IV GP LP10% Owner2026-02-06630,881$18.00
$11.36MBuy
Column Group IV GP LP10% Owner2026-02-061,437,323$18.00
$25.87MBuy
Lux Venture Partners V LLC10% Owner2026-02-04138,888$18.00
$2.50MBuy
Josh WolfeDirector2026-02-04138,888$18.00
$2.50MBuy
Josh WolfeDirector2026-02-04138,888$18.00
$2.50MBuy
Foresite Capital Management IV LLC10% Owner2026-02-0455,555$18.00
$999.99kBuy
Kenneth C. FrazierDirector2026-02-04111,111$18.00
$2.00MBuy
Lux Venture Partners V LLC10% Owner2026-02-04138,888$18.00
$2.50MBuy

1 of 1

EIKN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EIKN insiders and whales buy or sell their stock.

EIKN Shareholders

What type of owners hold Eikon Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Column Group IV GP LP21.51%11,652,838$60.01MInsider
Josh Wolfe4.23%2,294,653$11.82MInsider
Lux Venture Partners V LLC4.23%2,294,653$11.82MInsider
Roger M. Perlmutter2.72%1,475,856$7.60MInsider
Foresite Capital Management IV LLC2.43%1,318,983$6.79MInsider
Kenneth C. Frazier0.21%111,111$572.22kInsider
Alfred Lloyd Bowie Jr.0.10%51,572$265.60kInsider
Fmr LLC0.01%5,520$28.43kInstitution
Blackrock Inc0.01%4,869$25.08kInstitution
Foresite Capital Management IV LLC0.00%1,943$10.01kInstitution

1 of 3

EIKN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EIKN0.06%35.43%Net BuyingNet Buying
AUTL0.05%0.54%Net BuyingNet Buying
KYTX0.06%41.95%Net Buying
AGMB0.06%0.32%Net BuyingNet Buying
FULC0.10%55.84%Net Selling

Eikon Therapeutics Stock Ownership FAQ

Who owns Eikon Therapeutics?

Eikon Therapeutics (NASDAQ: EIKN) is owned by 0.06% institutional shareholders, 35.43% Eikon Therapeutics insiders, and 64.51% retail investors. Column Group IV GP LP is the largest individual Eikon Therapeutics shareholder, owning 11.65M shares representing 21.51% of the company. Column Group IV GP LP's Eikon Therapeutics shares are currently valued at $60.25M.

If you're new to stock investing, here's how to buy Eikon Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.